Table 1.
Characteristic | k | Min | Q1 | Mdn | Q3 | Max |
---|---|---|---|---|---|---|
Total number of treatment subjects at outcome | 112 | 8 | 30 | 56 | 154 | 3407 |
Total number of control subjects at outcome | 112 | 5 | 26 | 51 | 144 | 3406 |
Percentage attrition across treatment & control subjects | 93 | 0 | 0 | 8.1 | 23.1 | 82.2 |
Percentage from underrepresented ethnic/racial groups in North America, Europe, and Australia studies | 45 | 5 | 52.7 | 75 | 100 | 100 |
Percentage female | 98 | 0 | 45 | 57 | 66 | 100 |
Mean age (years) | 90 | 39 | 54.5 | 59.2 | 63.8 | 77.4 |
Mean number of prescribed medications | 9 | 1.93 | 3.1 | 5.1 | 5.5 | 6.93 |
Number of intervention sessions | 71 | 1 | 2 | 4 | 8 | 52 |
Minutes per intervention session | 29 | 6 | 12 | 20 | 35 | 90 |
Days over which the intervention was delivered | 94 | 1 | 84 | 183 | 224 | 732 |
Note. Includes all studies that contributed at least one effect size to primary analyses.
k denotes number of comparisons providing data on characteristic.
Min=minimum, Q1=first quartile, Mdn=median, Q3=third quartile, Max=maximum.